Literature DB >> 19349170

In-vessel bioreduction provides an effective storage and pre-treatment method for livestock carcasses prior to final disposal.

A Prysor Williams1, Gareth Edwards-Jones, David L Jones.   

Abstract

The EU Animal By-Products Regulations forbid the burial of livestock carcasses on land. Farmers would benefit from the availability of biosecure and economically viable alternatives for storing and disposing of dead animals. We assessed the efficacy of bioreduction vessels as a mechanism of storing and reducing the volume of fallen livestock prior to ultimate disposal. Two experimental scenarios were tested: (1) a single input of 300 kg of dead sheep with no further inputs for 3 months, and (2) a continuous 'on-farm' addition of dead sheep over 12 months (ca. 2-3t animals vessel(-1)). The trials involved half-filling the vessels with water, addition of the dead sheep with subsequent heating (40 degrees C) and aeration of the liquor. Each trial was repeated three times. Our results showed a complete biodigestion and liquefaction of the animals alongside a significant bioreduction in the volume of the liquid. No pathogens could be detected in either the waste or the gaseous emissions. Calculations showed that bioreduction may offer significant long-term savings for farmers in terms of animal disposal costs. Our findings suggest that bioreduction may offer a practical, biosecure, and cost-effective method of storing fallen livestock prior to disposal via rendering or incineration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19349170     DOI: 10.1016/j.biortech.2009.03.018

Source DB:  PubMed          Journal:  Bioresour Technol        ISSN: 0960-8524            Impact factor:   9.642


  1 in total

1.  Efficacy of NH3 as a secondary barrier treatment for inactivation of Salmonella Typhimurium and methicillin-resistant Staphylococcus aureus in digestate of animal carcasses: Proof-of-concept.

Authors:  Jacek A Koziel; Timothy S Frana; Heekwon Ahn; Thomas D Glanville; Lam T Nguyen; J Hans van Leeuwen
Journal:  PLoS One       Date:  2017-05-05       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.